New members in the Optibody Family!

Have you ever tested our Optibodies™-antibodies? The set of clinically important antibodies that fulfill the highest demands of any IHC procedure.

If not, now is the perfect opportunity, as we are proudly presenting our new upcoming Optibodies™! Ten new Optibody members; six rabbit and four mouse monoclonal Optibodies™ that are carefully optimized as per BioSiteHisto’s high criteria of optimal staining pattern. We would like to highlight two tremendously interesting rabbit monoclonal OptibodiesTM; CD79a (BSR20) and CK20 (BSR7). CD79a is an excellent marker for B-cell neoplasia together with CD20. Our BS20 clone offers excellent performance with high signal to noise ratio.

CK20 is a marker of colon carcinomas. Our rabbit monoclonal BSR7 clone offers great staining pattern and intensive staining in colorectal carcinoma cells. Test our CD79a and CK20 Optibodies™, as well as our other antibodies from our OptibodiesTM portfolio.

The other upcoming OptibodiesTM are: CD2 (BS60), CD4 (BSR4), CD8 (BSR5), CD38 (BSR7), CD43 (BS62), Beta catenin (BS31), Glutamine synthetase (BS51), and Cytokeratin 8 (BSR15). These antibodies offer great signal to noise ratio with intensive and specific staining, and they certainly are a welcome supplement in our Optibody™ collection.

Request free trial samples (50 µl) of any Optibody! Read more:


BSH-4000, CK8 [BSR15] – Ductal breast carcinoma

CD2_BS60_ 1-200_Tonsil

BSH-9399, CD2 [BS60] – Tonsil


BSH-3004, CD4 [BSR4] – Tonsil